Kevin T Conroy
CIK 1306119 · President and CEO · last filed 2026-07-01
Kevin T Conroy is a President and CEO who has filed 159 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for ABT, was dated Jul 1, 2026. Across all open-market trades the lifetime net is −$170.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.74M
7
159
-$170.46M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABT | Director | 133,737 | $108.62 | $14.53M | $0 | 2 | 2026-07-01 |
| ALGN | Director | 3,553 | $176.04 | $625.5K | $0 | 4 | 2026-05-22 |
| EXACT SCIENCES CORP (EXAS) Delisted | President and CEO | 0 | $104.91 | $0 | -$170.51M | 110 | 2026-03-23 |
| ADPT | Director | 22,968 | $25.45 | $584.5K | $0 | 4 | 2023-03-08 |
| Epizyme, Inc. (EPZM) Delisted | Director | 62,318 | $1.47 | $91.6K | $0 | 20 | 2022-07-05 |
| SomaLogic, Inc. (SLGCW) Delisted | Director | 25,000 | $0.09 | $2.1K | $0 | 1 | 2021-09-03 |
| THIRD WAVE TECHNOLOGIES INC /WI (TWTI) Delisted | President & CEO | 54,811 | — | — | $48.5K | 9 | 2008-05-09 |
Recent Filings
159 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | ABT | Grant (A) | — | $0 | EDGAR |
| 2026-05-22 | ALGN | Mixed | +1,745 | $0 | EDGAR |
| 2026-04-28 | ABT | Grant (A) | +2,286 | $0 | EDGAR |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −1,558,202 | $0 | EDGAR |
| 2026-03-03 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +36,090 | -$3.30M | EDGAR |
| 2026-02-27 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +6,985 | -$641.0K | EDGAR |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +378,382 | -$34.17M | EDGAR |
| 2025-05-22 | ALGN | Mixed | +1,148 | $0 | EDGAR |
| 2025-03-10 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +17,794 | -$809.3K | EDGAR |
| 2025-03-04 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +21,363 | -$906.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.